Blog
A pharmacy benefit manager stopped covering a GLP-1 for obesity. Now there’s a lawsuit
Truveta experts: Real-world trends in Rituxan biosimilar adoption
Shifting trends in initiation of disease-modifying therapies for multiple sclerosis
New AAP guidelines are changing pediatric obesity treatment—but there’s still work to do
Truveta experts: Treatment trends for trigeminal neuralgia
Kennedy Rescinds Endorsements for Some Flu Vaccines
Real-world survival outcomes for CRT and CCM therapies align with landmark trials
